Gilead Sciences Inc articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/07/31 03:22
2014/07/31 03:22
1m
WASHINGTON (AP) — The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than...
2014/07/31 03:22
2014/07/31 03:22
Latest videos
2014/07/30 13:08
2014/07/30 13:08
12h
Today's headlines include a range of health policy headines, including news from Capitol Hill on the Senate confirmation of Robert McDonald to head the VA. Kaiser Health News staff writer Julie...
2014/07/29 11:12
2014/07/29 11:12
1d
Illinois Medicaid restricts who can get 'game-changing' hepatitis drug Health Care Headlines Following the lead of other states, Illinois Medicaid officials have put in place tight criteria on...
2014/07/29 10:58
2014/07/29 10:58
1d
Israel hits symbols of Hamas power, Gaza's only power plant, in heaviest bombardment of war GAZA CITY, Gaza Strip (AP) — Israel struck symbols of Hamas' control of Gaza and the strip's only power...
2014/07/28 14:37
2014/07/28 14:37
2d
FDA Approves Idelalisib (Zydelig) for Leukemia and Lymphoma Article date: July 28, 2014 By Eleni Berger People with certain types of leukemia and lymphoma that has returned after treatment now have...
2014/07/28 10:17
2014/07/28 10:17
2d
CORK, Ireland--(BUSINESS WIRE)--Results from the Phase 2 COSMOS (Combination Of SiMeprevir and sOfosbuvir in HCV genotype 1 infected patientS) clinical study were published July 28 in The Lancet,...
2014/07/27 10:17
2014/07/27 10:17
3d
FOSTER CITY, Californië (VS)--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) heeft vandaag haar bedrijfsresultaten bekendgemaakt voor het kwartaal eindigend op 30 juni 2014. De totale...
2014/07/27 04:17
2014/07/27 04:17
3d
FOSTER CITY, Kalifornien (USA)--(BUSINESS WIRE)--Das Unternehmen Gilead Sciences, Inc. (Nasdaq: GILD), hat heute seine Betriebsergebnisse für das am 30. Juni 2014 beendete Quartal bekannt gegeben. Der...
2014/07/26 07:08
2014/07/26 07:08
4d
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) applauds the new licensing agreement between the Medicines Patent Pool (MPP) and Gilead Sciences, Inc. to improve access to tenofovir alafenamide...
2014/07/26 04:17
2014/07/26 04:17
4d
FOSTER CITY, Californie--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq : GILD) a annoncé aujourd’hui ses résultats d’exploitation pour le trimestre clos au 30 juin 2014. Le chiffre d’affaires total...
2014/07/26 01:17
2014/07/26 01:17
5d
L'Agenzia per gli Alimenti e i Medicinali statunitense (Food and Drug Administration, FDA) approva Zydelig® (idelalisib) di Gilead per il trattamento della leucemia linfocitica cronica recidivante,...
2014/07/25 19:39
2014/07/25 19:39
5d
After Janet Yellen said earlier this month that the valuations on some social media and biotech stocks are “stretched,” investors had a moment of reflection, driving down share prices over concerns...
2014/07/25 07:08
2014/07/25 07:08
5d
Sales of the new hepatitis C drug Sovaldi reached $3.5 billion in the second quarter, putting it on track to become one of the world's best-selling medicines and intensifying concerns about its costs....
2014/07/24 21:17
2014/07/24 21:17
6d
FOSTER CITY, California--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) ha anunciado que la Administración de Alimentos y Fármacos (FDA en sus siglas en inglés) de Estados Unidos, ha aprobado...
2014/07/24 13:14
2014/07/24 13:14
6d
The research was discussed Tuesday at the International AIDS Conference in Melbourne, Australia, and was published by the British journal Lancet Infectious Diseases. It involves 1,600 gay men and...
2014/07/24 13:08
2014/07/24 13:08
6d
Today's headlines include more analysis of this week's conflicting appeals courts' decisions regarding a key part of the health law. Kaiser Health News staff writers Mary Agnes Carey and Julie Rovner...
2014/07/24 13:06
2014/07/24 13:06
6d
Facebook jumped 8.8 percent after saying second-quarter sales surged 61 percent. Ford gained 1.6 percent as profit topped estimates. Qualcomm Inc. (QCOM) declined 4.9 percent after forecasting...
2014/07/24 12:18
2014/07/24 12:18
6d
... Stocks: Futures Up As Ford, Facebook Rise Premarket Stock futures rose on Thursday as well-received earnings lifted shares of Facebook Inc. and Ford Motor Co. on a busy day for corporate...
2014/07/24 04:17
2014/07/24 04:17
6d
MELBOURNE, Australia--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ:GILD) announced today at the 20th International AIDS Conference in Melbourne, Australia, a new agreement with the Medicines Patent...
2014/07/24 01:53
2014/07/24 01:53
6d
Amid concerns over the high cost of its new treatment for hepatitis C, drugmaker Gilead Sciences Inc. reported $5.8 billion in sales for its blockbuster Sovaldi drug in the first half of 2014. The...
2014/07/31 03:22
2014/07/31 03:22
Latest from Twitter